Evidence map›Paper›PMID 35983237›Full record

ArticlePalliative medicine reports2021

Interior Design: A New Perspective in Supportive Care of Patients with Acute Onset of Debilitating Diseases.

Davide Mauri, Eleftherios Kampletsas, George Smyris, Lampriani Tsali, Periklis Tsekeris, Haralampos Harissis, Konstantinos Kamposioras, Maria Tolia, Thomas Hyphantis, Panagiotis Ntellas and 7 more

Abstract read
In one paragraph

Article in Palliative medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Davide MauriDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.ORCID https://orcid.org/0000-0002-8501-5986
Eleftherios KampletsasDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
George SmyrisDepartment of Architectural Engineering, Architecture Faculty, University of Ioannina, Ioannina, Greece.
Lampriani TsaliPACMeR, Department of Evidence Based Medicine, Athens, Greece.
Periklis TsekerisDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Haralampos HarissisDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Konstantinos KamposiorasDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Maria ToliaDepartment of Radiotherapy, School of Medicine, University of Crete, Heraklion, Greece.
Thomas HyphantisDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Panagiotis NtellasDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Ioanna GazouliDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Georgios ZarkavelisDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Leonidas MavroeidisDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Anna-Lea AmylidiDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Nanteznta TorounidouDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Aristeidis GogadisDepartment of Medical Oncology, Psychiatry, Radiotherapy, and Surgery, University Hospital of Ioannina, Ioannina, Greece.
Joanna NixonDepartment of Radiotherapy, Scottish Sarcoma Network (SSN) UK Chair NCRIHN Epidemiology and Survivorship Subgroup, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Upon the onset of a debilitating rapidly evolving condition (such as cancer or a rapidly progressing myopathy, neuropathy, respiratory disease, or a severe traumatic injury), individuals have limited time to find a new home or make radical structural modifications in their residence. How the affected patients can continue sharing the same house with their families, while meeting their own special requirements, is thus rising as a critical issue. Household and daily routine rearrangements, either temporary or permanent, may be necessary, to ameliorate the life of patients with impairments, lasting for months or even years. Objectives: Interior design may provide a highly efficient "living" palliation for debilitating medical conditions directly at patients' home-site. Methods: Research of relevant literature, using keywords "debilitating conditions," "home care," "end of life care," "care of advanced cancer patients," "care of patients with mental disorders," "home care of covid-19 affected patients," and "care of patients with degenerative illnesses." Results: We found that patients and their relatives may not be aware of the probable interior design solutions to their daily life challenges, imposed by a disease-related impairment. In parallel, interior design experts may equally be unaware of these issues, as well as of who needs the available solutions.Similarly, medical and architectural sciences are not connected, eventually failing to meet patients' everyday needs. Conclusions: Interior architecture and health scientists are called to cooperate, aiming to provide a highly efficient and meaningful support to patients and families affected by unforeseen debilitating medical conditions.

Indexed as

aging populationdebilitating diseasesfunctional indoor spaceinterior designmedical caresupportive care

Identifiers

PMID35983237
PMCPMC9380877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.